Compare RBOT & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBOT | EDAP |
|---|---|---|
| Founded | 2014 | 1979 |
| Country | United States | France |
| Employees | 131 | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1M | 75.5M |
| IPO Year | N/A | 1997 |
| Metric | RBOT | EDAP |
|---|---|---|
| Price | $2.43 | $2.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.00 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 159.3K | 67.9K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $74,853,925.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.61 |
| 52 Week Low | $2.36 | $1.21 |
| 52 Week High | $18.97 | $3.44 |
| Indicator | RBOT | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 35.35 | 57.17 |
| Support Level | $2.37 | $2.58 |
| Resistance Level | $2.58 | $3.44 |
| Average True Range (ATR) | 0.30 | 0.27 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 9.23 | 48.05 |
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.